Oncimmune (LON:ONC) Stock Price Down 0.6% – What’s Next?

Oncimmune Holdings plc (LON:ONC) traded down 0.6% during mid-day trading on Wednesday . The stock traded as low as GBX 14.73 ($0.19) and last traded at GBX 15.65 ($0.20). 8,700 shares traded hands during trading, a decline of 93% from the average session volume of 124,152 shares. The stock had previously closed at GBX 15.75 ($0.20).

Oncimmune Stock Performance

The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85. The company has a 50-day moving average price of GBX 15.26 and a 200-day moving average price of GBX 15.10. The firm has a market capitalization of £10.87 million, a price-to-earnings ratio of -488.67 and a beta of 1.19.

Oncimmune Company Profile

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.